Review of the safety and efficacy of voriconazole

VERWEIJ PE, 1999, J Clin Microbiol, 37, 1606, 10.1128/JCM.37.5.1606-1609.1999

10.1086/322653

10.1046/j.1365-2230.2001.00909.x

10.1086/317496

10.1136/bjo.84.8.928d

10.1038/clpt.1988.87

10.1016/0140-6736(91)92302-I

10.2165/00002018-199920020-00005

BLACK DJ, 1996, II. A metabolically based drug interaction: in vivo studies. Drug Metab. Dirpos, 24, 422

KO JW, 1997, Drug Metab. Dispos., 25, 853

10.1093/clinids/18.2.259

10.1093/clind/16.3.400

FUHR U, 1998, Extent, probable mechanism and clinical relevance. Drug Sal, 18, 251

10.1080/mmy.38.3.209.212

EMORI TG, 1993, Clin. Microbial Rev, 6, 428, 10.1128/CMR.6.4.428

10.1016/S0732-8893(97)00115-6

10.1128/AAC.44.3.747-751.2000

10.1007/s100960050313

10.1016/S0732-8893(98)00005-4

NGUYEN MH, 1998, Antimicrob. Agents Chemother., 42, 471, 10.1128/AAC.42.2.471

10.1093/jac/46.2.338

RUHNKE M, 1997, Antimicrob. Agents Chemother, 41, 575, 10.1128/AAC.41.3.575

10.1016/S0732-8893(00)00177-2

10.1128/AAC.44.7.1917-1920.2000

10.1080/00365549950164049

10.1179/joc.1999.11.1.34

HEGENER P, 1998, Aids, 12, 2227

HOBAN DJ, 1999, Antimicrob. Agents Chemother., 43, 1463, 10.1128/AAC.43.6.1463

10.1093/oxfordjournals.jac.a020873

10.1007/s100960050484

MONDON P, 1999, Antimicrob. Agents Chemother., 43, 1856, 10.1128/AAC.43.8.1856

10.1227/00006123-199504000-00032

10.1086/322606

10.1016/0002-9343(94)90023-X

10.1093/clinids/23.3.608

OAKLEY KL, 1998, and comparison with itraconazole and amphotericin B. Antimicrob. Chemother, 42, 91

MARCO F, 1998, Med. Myra, 36, 433

10.1016/S0732-8893(98)00102-3

10.1093/jac/42.6.741

10.1093/jac/42.3.389

WILDFEUER A, 1997, Arzneimittelforschung, 47, 1257

10.1111/j.1439-0507.1998.tb00344.x

10.1128/AAC.45.2.605-607.2001

SUTTON DA, 1999, Clin. Microbiol, 37, 2343, 10.1128/JCM.37.7.2343-2345.1999

MANAVATHU EK, 1998, Antimicrob. Agents Chemother, 42, 3018, 10.1128/AAC.42.11.3018

GEORGE D, 1996, Antimicrob. Agents Chemother, 40, 86, 10.1128/AAC.40.1.86

10.1128/AAC.44.10.2865-2868.2000

MARTIN MV, 1997, Antimicrob. Agents Chemother, 41, 13, 10.1128/AAC.41.1.13

MURPHY M, 1997, Antimicrob. Agents Chemother, 41, 696, 10.1128/AAC.41.3.696

10.1086/517646

10.1038/sj.bmt.1702651

VERWEIJ PE, 2000, Clin. Microbial., 38, 3900, 10.1128/JCM.38.10.3900-3901.2000

RADFORD SA, 1997, Antimicrob. Agents Chemother, 41, 841, 10.1128/AAC.41.4.841

CLANCY CJ, 1998, Ear: j Clin. Microbial. Infect. Dis., 17, 573

10.1086/314042

GIRMENIA C, 1998, J. Clin. Microbiol, 36, 1436, 10.1128/JCM.36.5.1436-1438.1998

10.1128/AAC.45.2.601-604.2001

10.1128/AAC.45.2.633-635.2001

10.1046/j.1439-0507.2000.00585.x

MCGINNIS MR, 1998, Med. Myra, 36, 239

RYDER NS, 2001, Med. Myra, 39, 91

10.1128/AAC.45.3.966-968.2001

10.1093/jac/42.2.253

10.1093/jac/43.1.149

10.1093/jac/44.5.697

BARRY AL, 1996, Antimicrob. Agents Chemother., 40, 1948, 10.1128/AAC.40.8.1948

PFALLER MA, 1998, Antimicrob. Agents Chemother., 42, 3242, 10.1128/AAC.42.12.3242

PFALLER MA, 2000, I Clin. Microbiol, 38, 3715, 10.1128/JCM.38.10.3715-3717.2000

MARCO F, 1998, Antimicrob. Agents Chemother, 42, 161, 10.1128/AAC.42.1.161

10.1159/000007320

MCGINNIS MR, 1997, Antimicrob. Agents Chemother, 41, 1832, 10.1128/AAC.41.8.1832

10.1128/AAC.44.6.1734-1736.2000

10.1128/AAC.45.7.2151-2153.2001

10.1128/AAC.45.9.2524-2528.2001

10.1128/JCM.39.1.385-388.2001